Euclidean Capital LLC Portfolio Holdings
Euclidean Capital LLC
- $304 Million
- Q2 2025
Euclidean Capital LLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $304 Million distributed in 11 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Vanguard Ftse All World Ex Us with a value of $144M, Ishares Msci India Index Fund with a value of $135M, Oric Pharmaceuticals, Inc. with a value of $10M, Foghorn Therapeutics Inc. with a value of $7.4M, and Pmv Pharmaceuticals, Inc. with a value of $2.79M.
Examining the 13F form we can see an increase of $39.2M in the current position value, from $265M to 304M.
Euclidean Capital LLC is based out at New York, NY
Below you can find more details about Euclidean Capital LLC portfolio as well as his latest detailed transactions.